Perioperative right ventricular function and dysfunction in adult cardiac surgery—focused review (part 2—management of right ventricular failure)

被引:0
作者
Praveen Kerala Varma
Balaji Srimurugan
Reshmi Liza Jose
Neethu Krishna
George Jose Valooran
Aveek Jayant
机构
[1] Amrita Viswa Vidyapeetham (Amrita University),Divisions of Cardio Thoracic Surgery, Amrita Institute of Medical Sciences
[2] Amrita Viswa Vidyapeetham (Amrita University),Divisions of Cardiac Anesthesiology, Amrita Institute of Medical Sciences
[3] Rajagiri Hospital,Division of Cardiac Surgery
来源
Indian Journal of Thoracic and Cardiovascular Surgery | 2022年 / 38卷
关键词
Right ventricular failure; Right-sided heart failure; Perioperative; Management; Assist devices;
D O I
暂无
中图分类号
学科分类号
摘要
The single most important factor in improving outcomes in right ventricular (RV) failure is anticipating and recognizing it. Once established, a vicious circle of systemic hypotension, and RV ischemia and dilation, occurs, leading to cardiogenic shock, multi-organ failure, and death. RV dysfunction and failure theoretically can occur in three settings—increase in the pre-load; increase in after load; and decrease in contractility. For patients deemed low risk for the development of RV failure, when it occurs, the correction of underlying cause is the most important and effective treatment strategy. Therapy of RV failure must focus on improving the RV coronary perfusion, lowering pulmonary vascular resistance, and optimizing the pre-load. Pre-load and after-load optimization, ventilator adjustments, and improving the contractility of RV by inotropes are the first line of therapy and should be initiated early to prevent multi-organ damage. Mechanical assist device implantation or circulatory support with extracorporeal membrane oxygenation (ECMO) may be needed in refractory cases.
引用
收藏
页码:157 / 166
页数:9
相关论文
共 184 条
[1]  
Wanner PM(2020)The right ventricle-you may forget it, but it will not forget you J Clin Med 9 432-822
[2]  
Filipovic M(2014)Management of acute right ventricular failure in the intensive care unit Ann Am Thorac Soc 11 811-87
[3]  
Ventetuolo CE(2021)Change in right ventricular systolic function after continuous renal replacement therapy initiation and renal recovery J Crit Care 62 82-92
[4]  
Klinger JR(2015)Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1 Clin Kidney J 8 87-1284
[5]  
Shawwa K(1993)Inhaled nitric oxide: dose response and the effects of blood in the isolated rat lung J Appl Physiol (1985) 75 1278-950
[6]  
Kompotiatis P(2004)Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery J Thorac Cardiovasc Surg 128 949-901
[7]  
Wiley BM(1984)Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease J Am Coll Cardiol 4 890-855
[8]  
Jentzer JC(2011)Vasoactive drugs in circulatory shock Am J Respir Crit Care Med 183 847-821
[9]  
Kashani KB(1997)Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension Ann Thorac Surg 63 814-1492
[10]  
Prins KW(2006)Effects of levosimendan on right ventricular function in patients with advanced heart failure Am J Cardiol 98 1489-95